A Study to Evaluate Unintended Prolonged Opioid Use

Overview

About this study

The primary purpose of this study is to identify patient characteristics that are associated with unintended prolonged opioid use (UPUO).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

Inclusion Criteria:

  • Age ≥ 18 years old.
  • No use of opioids for 6 months prior to the issuance of the initial opioid prescription.
  • Agree to use Hugo Platform on their personal smartphone or an iPad.

Exclusion Criteria:

  • Cancer-associated pain.
  • Concurrent treatment for cancer (e.g., chemotherapy, radiation therapy).
  • Residence in an extended care facility.
  • Mental health disorders that could impede functioning in an ambulatory care setting (e.g., schizophrenia, dementia).
  • Non-English speaking individuals.
  • Use of mail-order pharmacies.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

William Hooten, M.D.

Open for enrollment

Contact information:

Brenda Anderson R.N.

(507)255-7157

anderson.brenda@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available